Merck Serono Japan Releases Erbitux Post-market Surveillance Report
This article was originally published in PharmAsia News
Executive Summary
Merck Serono Japan unveiled a report summarizing all-case post-market surveillance cases for Erbitux (cetuximab) in Japan